Announced Mon, 5 Oct, 2026 · 17:28 IST
Prasol Q1 FY27 transcript filed; revenue up 36%, EBITDA doubles
Mgmt Guided Margin ImprovementAnalyst Day Multiyear TargetsInvestor Communications View source PDFExplain this filing
PRASOLCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+10.1%1-day move
₹795.00
prior close
₹791.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.4+2.3+3.6+5.7+10.1+11.4————————
Up moveDown movePending
AI summary
Prasol filed Q1 FY27 earnings transcript. Revenue rose 35.7% YoY to INR433.6 cr, aided by inventory gains from geopolitical price spikes. EBITDA more than doubled to INR90.3 cr, margin 20.8% vs 12.7%. PAT grew 151% to INR61 cr. FY27 guidance: revenue INR1,550-1,650 cr, EBITDA INR240-250 cr ex-price/forex. Sustainable gross margins guided at 30-32%. 5-year revenue target INR2,800-3,000 cr. Phase 1 capex INR250-300 cr over 2 years.
Likely market impact
Strong Q1 beat with EBITDA more than doubling; 5-year revenue target of INR2,800-3,000 cr signals long-term growth ambitions. Recently listed company.